Concepedia

Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission

Evgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, Ulrike Fritzsche‐Friedland, Petra Freiberger, Francis Ayuk, Christine Wolschke, Ulrike Bacher, Nicolaus Kröger

Transplantation and Cellular Therapy · 2022 · 15 citations · 43 references

DOIFull text

Open access

Concepts

References

43

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

Bruce D. Cheson, John M. Bennett, Thomas Büchner et al. · Journal of Clinical Oncology · 2003 · 2.7K citations

, , +17

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

Christopher S. Hourigan, Laura W. Dillon, Gege Gui et al. · Journal of Clinical Oncology · 2019 · 442 citations · Full text

, , +17

Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

Roland B. Walter, Ted Gooley, Brent L. Wood et al. · Journal of Clinical Oncology · 2011 · 399 citations · Full text

, , +15

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

Mehdi Alizadeh, Marc Bernard, Bruno Danic et al. · Blood · 2002 · 363 citations · Full text

, , +16

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Uwe Platzbecker, Jan Moritz Middeke, Katja Sockel et al. · The Lancet Oncology · 2018 · 354 citations

, , +17